miltefosine has been researched along with Anemia in 1 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
Excerpt | Relevance | Reference |
---|---|---|
"Mucocutaneous leishmaniasis is a serious preventable complication of cutaneous leishmaniasis." | 1.35 | [Mucosal complication of cutaneous leishmaniasis]. ( Figueroa, RA; Miranda, MC; Prager, M; Zea, DF, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zea, DF | 1 |
Prager, M | 1 |
Figueroa, RA | 1 |
Miranda, MC | 1 |
1 other study available for miltefosine and Anemia
Article | Year |
---|---|
[Mucosal complication of cutaneous leishmaniasis].
Topics: Aged; Anemia; Antiprotozoal Agents; Contraindications; Eyelid Diseases; Humans; Hypertension; Kidney | 2009 |